Patents by Inventor Peter Svete

Peter Svete has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preparing stabilized pharmaceutical compositions comprising active ingredients susceptible to conversion to alternate polymorph forms
    Publication number: 20110021631
    Abstract: A process is described for the preparation of a pharmaceutical comprising an active pharmaceutical ingredient capable of existing in multiple polymorphic forms, wherein the process comprises a step of preparation of a wet phase comprising the active pharmaceutical ingredient and microcrystalline cellulose and a liquid, wherein in the wet phase has a weight ratio of active pharmaceutical ingredient to microcrystalline cellulose above 1.0 or a weight ratio of active pharmaceutical ingredient to liquid above 1.0.
    Type: Application
    Filed: September 9, 2010
    Publication date: January 27, 2011
    Applicant: LEK PHARMACEUTICALS D.D.
    Inventor: Peter SVETE
  • Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate
    Publication number: 20100120868
    Abstract: The invention relates to a process for preparing a solid pharmaceutical composition rosiglitazone maleate, comprising the step of adsorption of rosiglitazone maleate onto carrier particles (C) during a dry mixing process.
    Type: Application
    Filed: November 6, 2009
    Publication date: May 13, 2010
    Inventors: Tijana Stanic Ljubin, Sebastjan Reven, Miha Tomaz Jaklic, Peter Svete
  • Bursting Pellets
    Publication number: 20100034887
    Abstract: In the present invention, a new pharmaceutical formulation of bursting pellets comprising in the core a high dose of a low potency active substance which is poorly soluble in water is described. Release of the active substance from the core takes place within minutes.
    Type: Application
    Filed: December 21, 2006
    Publication date: February 11, 2010
    Applicant: LEK Pharmaceuticals D.D.
    Inventors: Polonca Kuhar, Peter Svete, Judita Sirca
  • Pharmaceutical Composition Comprising Perindopril or Its Salts
    Publication number: 20090136578
    Abstract: The present invention relates to a stable pharmaceutical composition of the ACE inhibitor perindopril or its salts having a defined particle size distribution.
    Type: Application
    Filed: August 28, 2006
    Publication date: May 28, 2009
    Applicant: LEK Pharmaceutical d.d.
    Inventor: Peter Svete
  • Pharmaceutical Composition
    Publication number: 20080242725
    Abstract: Stabilized pharmaceutical compositions comprising polymorphs of active pharmaceutical ingredients susceptible to conversion to alternate polymorph forms are prepared by a process of wet granulation in which the ratios of active, fillers, and granulating liquid are controlled in order to avoid polymorphic interconversions.
    Type: Application
    Filed: February 28, 2005
    Publication date: October 2, 2008
    Inventors: Janez Kerc, Peter Svete, Zdenka Jerala-Strukelj, Vlasta Humar, Rok Grahek, Breda Husu-Kovacevic
  • Pharmaceutical Formulation
    Publication number: 20070298108
    Abstract: Composition were developed which stabilize an active pharmaceutical ingredient in polymorph form susceptible to degradation or interconversion into other polymorph forms, where stabilizing substance is conveniently among silicon dioxide, silicified microcrystalline cellulose, magnesium oxide and polyethylene glycol.
    Type: Application
    Filed: February 28, 2005
    Publication date: December 27, 2007
    Inventors: Peter Svete, Rok Grahek, Vlasta Humar, Breda Husu-Kovacevic, Zdenka Jerala-Strukelj
  • Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
    Patent number: 7271269
    Abstract: Pharmaceutically suitable crystalline and amorphous alkali and earth-alkali salts of 2-n-butyl-4-chloro-5-hidrox-ymethyl-1-[[2?-(1 H-tetrazole-5-yl)[1.1?-biphenyl]-4-yl]-1 Himidazole have been prepared and new manufacturing, purification and isolation procedure for said salts in high purity have been described. Stable pharmaceutical compositions containing new crystalline potassium salts of 2-n-butyl-5-chloro-5hidroxymethyl-1-[[2?-(1H-tetrazole-5-yl)[1.1?-biphenyl]-44-yl]-1H-imidazole have been prepared.
    Type: Grant
    Filed: January 29, 2004
    Date of Patent: September 18, 2007
    Assignee: Lek Pharmaceuticals D.D.
    Inventors: Ljubomir Antoncic, Anton Copar, Peter Svete, Breda Husu-Kovacevic, Zoran Ham, Boris Marolt
  • Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
    Publication number: 20060004207
    Abstract: Pharmaceutically suitable crystalline and amorphous alkali and earth-alkali salts of 2-n-butyl-4-chloro-5-hidrox-ymethyl-1-[[2?-(1H-tetrazole-5-yl)[1.1?-biphenyl]-4-yl]-1 Himidazole have been prepared and new manufacturing, purification and isolation procedure for said salts in high purity have been described. Stable pharmaceutical compositions containing new crystalline potassium salts of 2-n-butyl-5-chloro-5hidroxymethyl-1-[[2?-(1H-tetrazole-5-yl)[1.1?-biphenyl]-44-yl]-1H-imidazole have been prepared.
    Type: Application
    Filed: January 29, 2004
    Publication date: January 5, 2006
    Inventors: Ljubomir Antoncic, Anton Copar, Peter Svete, Breda Husu-Kovacevic, Zoran Ham, Boris Marolt